相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease
Jeffrey R. Petrella et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2019)
Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau
Aysha S. Mohamed Lafirdeen et al.
PLOS ONE (2019)
Cognitive reserve and clinical progression in Alzheimer disease A paradoxical relationship
Anna Catharina van Loenhoud et al.
NEUROLOGY (2019)
Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework
Clifford R. Jack et al.
JAMA NEUROLOGY (2019)
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study
Bernard J. Hanseeuw et al.
JAMA NEUROLOGY (2019)
Linking Molecular Pathways and Large-Scale Computational Modeling to Assess Candidate Disease Mechanisms and Pharmacodynamics in Alzheimer's Disease
Leon Stefanovski et al.
FRONTIERS IN COMPUTATIONAL NEUROSCIENCE (2019)
Tau PET imaging in neurodegenerative tauopathies-still a challenge
Antoine Leuzy et al.
MOLECULAR PSYCHIATRY (2019)
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
Rik Ossenkoppele et al.
NEUROLOGY (2019)
NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease
Nina Silverberg et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
A hybrid computational approach for efficient Alzheimer's disease classification based on heterogeneous data
Xuemei Ding et al.
SCIENTIFIC REPORTS (2018)
Impact of amyloid-beta changes on cognitive outcomes in Alzheimer's disease: analysis of clinical trials using a quantitative systems pharmacology model
Hugo Geerts et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451
Azadeh Firouzian et al.
EJNMMI RESEARCH (2018)
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
Eric McDade et al.
NEUROLOGY (2018)
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
Ivan Koychev et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2016)
Biomarkers and Surrogate Endpoints Developing Common Terminology and Definitions
Melissa A. Robb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F}-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
Abbas M. Walji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
A Simulation Model of Periarterial Clearance of Amyloid-β from the Brain
Alexandra K. Diem et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
The critical need for defining preclinical biomarkers in Alzheimer's disease
Massimo S. Fiandaca et al.
ALZHEIMERS & DEMENTIA (2014)
Changes in White Matter Integrity before Conversion from Mild Cognitive Impairment to Alzheimer's Disease
Michaela Defrancesco et al.
PLOS ONE (2014)
Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects
Michael Ewers et al.
NEUROIMAGE-CLINICAL (2014)
Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2013)
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Masahiro Maruyama et al.
NEURON (2013)
Biomarker Modeling of Alzheimer's Disease
Clifford R. Jack et al.
NEURON (2013)
Investigating Interventions in Alzheimer's Disease with Computer Simulation Models
Carole J. Proctor et al.
PLOS ONE (2013)
Exploring the contribution of estrogen to amyloid-beta regulation: a novel multifactorial computational modeling approach
Thomas J. Anastasio
FRONTIERS IN PHARMACOLOGY (2013)
Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques
Ira Driscoll et al.
ACTA NEUROPATHOLOGICA (2012)
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
Peder Buchhave et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Proteomic Changes in Cerebrospinal Fluid of Presymptomatic and Affected Persons Carrying Familial Alzheimer Disease Mutations
John M. Ringman et al.
ARCHIVES OF NEUROLOGY (2012)
Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals
Maciej J. Lazarczyk et al.
BMC MEDICINE (2012)
Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies
Kejal Kantarci et al.
NEUROBIOLOGY OF AGING (2012)
MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults
Bradford C. Dickerson et al.
NEUROLOGY (2012)
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings
T. T. Seppala et al.
NEUROLOGY (2012)
CSF T-Tau/Aβ42 Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer's Disease
Barbara B. Bendlin et al.
PLOS ONE (2012)
Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug action
Patrick D. Roberts et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data
Andrei G. Vlassenko et al.
ANNALS OF NEUROLOGY (2011)
In Vivo Fibrillar β-Amyloid Detected Using [11C]PiB Positron Emission Tomography and Neuropathologic Assessment in Older Adults
Jitka Sojkova et al.
ARCHIVES OF NEUROLOGY (2011)
Cognitively Preserved Subjects with Transitional Cerebrospinal Fluid β-Amyloid 1-42 Values Have Thicker Cortex in Alzheimer's Disease Vulnerable Areas
Juan Fortea et al.
BIOLOGICAL PSYCHIATRY (2011)
Data-driven modeling of Alzheimer Disease pathogenesis
Thomas J. Anastasio
JOURNAL OF THEORETICAL BIOLOGY (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation
Michael Scholl et al.
NEUROBIOLOGY OF AGING (2011)
Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification
Christos Davatzikos et al.
NEUROBIOLOGY OF AGING (2011)
Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults
B. C. Dickerson et al.
NEUROLOGY (2011)
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Todd E. Golde et al.
NEURON (2011)
Identifying and validating biomarkers for Alzheimer's disease
Christian Humpel
TRENDS IN BIOTECHNOLOGY (2011)
Increased Brain Atrophy Rates in Cognitively Normal Older Adults with Low Cerebrospinal Fluid Aβ1-42
Jonathan M. Schott et al.
ANNALS OF NEUROLOGY (2010)
Biological markers of amyloid β-related mechanisms in Alzheimer's disease
Harald Hampel et al.
EXPERIMENTAL NEUROLOGY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
The clinical use of structural MRI in Alzheimer disease
Giovanni B. Frisoni et al.
NATURE REVIEWS NEUROLOGY (2010)
Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment
Sarah B. Martin et al.
NEUROBIOLOGY OF AGING (2010)
Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal
Liana G. Apostolova et al.
NEUROBIOLOGY OF AGING (2010)
Decreased Cerebrospinal Fluid Aβ42 Correlates with Brain Atrophy in Cognitively Normal Elderly
Anne M. Fagan et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
High Striatal Amyloid β-Peptide Deposition Across Different Autosomal Alzheimer Disease Mutation Types
Victor L. Villemagne et al.
ARCHIVES OF NEUROLOGY (2009)
Preclinical Evidence of Alzheimer Changes
Eric C. Petrie et al.
ARCHIVES OF NEUROLOGY (2009)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimers disease: implications for sequence of pathological events in Alzheimers disease
Clifford R. Jack et al.
BRAIN (2009)
The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals
Bradford C. Dickerson et al.
CEREBRAL CORTEX (2009)
Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
Anne M. Fagan et al.
EMBO MOLECULAR MEDICINE (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Biomarkers of Alzheimer's disease
Rebecca Craig-Schapiro et al.
NEUROBIOLOGY OF DISEASE (2009)
Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study
A. Okello et al.
NEUROLOGY (2009)
Age, Neuropathology, and Dementia
George M. Savva et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Howard Jay Aizenstein et al.
ARCHIVES OF NEUROLOGY (2008)
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Milos D. Ikonomovic et al.
BRAIN (2008)
Biochemical markers in persons with preclinical familial Alzheimer disease
J. M. Ringman et al.
NEUROLOGY (2008)
PIB is a non-specific imaging marker of amyloid-beta (Aβ) peptide-related cerebral amyloidosis
A. Lockhart et al.
BRAIN (2007)
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2007)
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
W. Jagust et al.
NEUROLOGY (2007)
CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment -: A follow-up study
G. Li et al.
NEUROLOGY (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees
William E. Klunk et al.
JOURNAL OF NEUROSCIENCE (2007)
Imaging β-amyloid burden in aging and dementia
C. C. Rowe et al.
NEUROLOGY (2007)
Cerebrospinal fluid β-amyloid 1-42 concentration may predict cognitive decline in older women
Deborah R. Gustafson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Molecular imaging with Pittsburgh compound B confirmed at autopsy - A case report
Brian J. Bacskai et al.
ARCHIVES OF NEUROLOGY (2007)
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2006)
[11]PIB in a nondemented population -: Potential antecedent marker of Alzheimer disease
M. A. Mintun et al.
NEUROLOGY (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Use of hippocamal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people
T den Heijer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Familial Alzheimer disease:: Decreases in CSF Aβ42 levels precede cognitive decline
M Moonis et al.
NEUROLOGY (2005)
Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism
EM Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly
JG Csernansky et al.
NEUROIMAGE (2005)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
EM Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cerebrospinal fluid β-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease:: The effect of APOE ε4 allele
T Sunderland et al.
BIOLOGICAL PSYCHIATRY (2004)
Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging
H Rusinek et al.
RADIOLOGY (2003)
Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: A population-based study in 85-year-olds
I Skoog et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
An energy budget for signaling in the grey matter of the brain
D Attwell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study
H Petrovitch et al.
NEUROLOGY (2001)
Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images
NC Fox et al.
LANCET (2001)
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
CR Jack et al.
NEUROLOGY (2000)
The molecular and genetic basis of AD: The end of the beginning - The 2000 Wartenberg lecture
RN Rosenberg
NEUROLOGY (2000)
分享论文
